Myomectomy associated blood transfusion risk and morbidity after surgery
Fertility and Sterility Jun 12, 2020
Kim T, Purdy MP, Kendall-Rauchfuss L, et al. - Via performing a retrospective cohort study of women who underwent myomectomies for symptomatic uterine fibroids (N = 3,407), researchers sought to determine blood transfusion risks and the linked 30-day postoperative morbidity after myomectomy. Blood transfusion was required in overall 10% cases (hysteroscopy, 6.7%; laparoscopy, 2.7%; open/abdominal procedures, 16.4%). Transfusion was noted to be independently related with following risk factors: black race and other race compared with white race; preoperative hematocrit < 30% compared with ≥ 30%; preoperative blood transfusion; high fibroid burden; prolonged surgical time; and open/abdominal approach. An approximately threefold increased risk for experiencing a major postoperative complication was observed for women who required blood transfusions even after adjusting for confounders.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries